Pharmaceutical Preparations - Latest Activist Disclosures

This table shows recent activist investor (Schedule 13D) filings made in this industry. Any investor or hedge fund that makes an investment with the intention of influencing management is considered an activist investor and must file a 13D.

Date Form Target Company Investor Shares Ownership
(Percent)		 Ownership Change
(Percent)
2025-09-23 13D/A LVTX / LAVA Therapeutics N.V. Versant Venture Capital VI, L.P. 0 0.00 -100.00
2025-09-23 13D/A ALZN / Alzamend Neuro, Inc. Ault Milton C Iii 606,321 15.90 -14.16
2025-09-22 13D/A XCUR / Exicure, Inc. HiTron Systems Inc. 3,333,333 52.80 0.00
2025-09-19 13D/A PGEN / Precigen, Inc. Kirk Randal J 146,295,359 39.40 25.21
2025-09-19 13D/A BFRI / Biofrontera Inc. Deutsche Balaton Aktiengesellschaft 2,552,230 19.99 456.18
2025-09-19 13D ARTL / Artelo Biosciences, Inc. Farb Daniel Stuart 153,000 9.80
2025-09-19 13D/A HYPD / Hyperion DeFi, Inc. Avenue Venture Opportunities Fund, L.P. 240,124 4.20 -32.22
2025-09-18 13D/A LVTX / LAVA Therapeutics N.V. Versant Venture Capital VI, L.P. 2,370,533 9.00 -30.42
2025-09-18 13D/A RDY / Dr. Reddy's Laboratories Limited - Depositary Receipt (Common Stock) G.V. Prasad 113,356,510 13.58
2025-09-17 13D/A HYPD / Hyperion DeFi, Inc. Avenue Venture Opportunities Fund, L.P. 354,291 6.20 -18.64
2025-09-15 13D/A DNTH / Dianthus Therapeutics, Inc. Fairmount Funds Management LLC 4,052,052 9.90 37.01
2025-09-12 13D TLPH / Talphera, Inc. CorMedix Inc. 9,090,909 19.95
2025-09-08 13D/A MLYS / Mineralys Therapeutics, Inc. Samsara BioCapital, L.P. 6,346,194 8.20 10.63
2025-09-08 13D/A MLYS / Mineralys Therapeutics, Inc. Ra Capital Management, L.p. 7,796,433 9.90 24.00
2025-09-05 13D/A TCRT / Alaunos Therapeutics, Inc. Pmgc Capital Llc 0 0.00 -100.00
2025-09-05 13D/A INDV / Indivior PLC Two Seas Capital LP 10,329,152 8.30 -11.43
2025-09-04 13D/A NBY / NovaBay Pharmaceuticals, Inc. Poplar Point Capital Management Llc 1,020,300 17.52 0.00
2025-09-04 13D/A PRQR / ProQR Therapeutics N.V. Van Herk Investments B.v. 13,274,690 12.60 8.79
2025-09-03 13D/A VTVT / vTv Therapeutics Inc. Samsara BioCapital, L.P. 343,223 9.90 29.22
2025-09-02 13D STTK / Shattuck Labs, Inc. Orbimed Advisors Llc 6,306,127 9.99
2025-09-02 13D/A CARM / Carisma Therapeutics, Inc. HealthCap VII, L.P. 0 0.00 -100.00
2025-08-29 13D/A CARM / Carisma Therapeutics, Inc. HealthCap VII, L.P. 2,014,372 4.80 -25.99
2025-08-28 13D/A ORMP / Oramed Pharmaceuticals Inc. Kidron Nadav 3,116,729 7.60 32.97
2025-08-26 13D/A STOK / Stoke Therapeutics, Inc. Blue Horizon Enterprise Ltd 2,256,181 4.10 -30.71
2025-08-26 13D/A STTK / Shattuck Labs, Inc. Redmile Group, LLC 6,379,095 9.90 12.85
2025-08-26 13D NBY / NovaBay Pharmaceuticals, Inc. Lazar David E. 1,200,048 19.99
2025-08-22 13D/A ARVN / Arvinas, Inc. Logos Global Management LP 6,300,000 8.60 31.25
2025-08-22 13D/A ANIP / ANI Pharmaceuticals, Inc. Meridian Venture Partners II GP, L.P. 1,034,570 4.80 -12.66
2025-08-21 13D/A CARM / Carisma Therapeutics, Inc. HealthCap VII, L.P. 2,721,923 6.50 -19.90
2025-08-21 13D/A KROS / Keros Therapeutics, Inc. ADAR1 Capital Management, LLC 5,389,264 13.27 -0.03
2025-08-20 13D/A NAMS / NewAmsterdam Pharma Company N.V. Frazier Life Sciences X, L.P. 7,327,937 6.50 -55.36
2025-08-20 13D/A KALV / KalVista Pharmaceuticals, Inc. Frazier Life Sciences Public Fund, L.P. 2,400,276 4.80 -50.89
2025-08-20 13D/A ARQT / Arcutis Biotherapeutics, Inc. Frazier Life Sciences VIII, L.P. 8,943,712 7.50 0.92
2025-08-20 13D/A PHAT / Phathom Pharmaceuticals, Inc. Frazier Life Sciences Public Fund, L.P. 5,985,327 8.60 -58.52
2025-08-20 13D/A MIRM / Mirum Pharmaceuticals, Inc. Frazier Life Sciences IX, L.P. 3,735,220 7.60 -40.01
2025-08-20 13D/A PRQR / ProQR Therapeutics N.V. Van Herk Investments B.v. 12,202,190 11.60 6.09
2025-08-19 13D/A IOBT / IO Biotech, Inc. Novo Holdings A/S 4,981,588 7.30 -14.46
2025-08-18 13D/A OSTX / OS Therapies Incorporated Auerbach Shalom 2,677,570 8.50 -0.37
2025-08-18 13D/A MRKR / Marker Therapeutics, Inc. New Enterprise Associates 16, L.P. 1,625,678 12.60 0.00
2025-08-15 13D/A BHC / Bausch Health Companies Inc. Icahn Partners Master Fund LP 0 0.00 -100.00
2025-08-15 13D/A ARWR / Arrowhead Pharmaceuticals, Inc. Sarepta Therapeutics, Inc. 0 0.00 -100.00
2025-08-15 13D/A IRON / Disc Medicine, Inc. Atlas Venture Fund X, L.P. 1,084,527 3.10 -22.65
2025-08-14 13D/A BHC / Bausch Health Companies Inc. Paulson & Co. Inc. 70,755,869 19.10 115.77
2025-08-14 13D/A BBIO / BridgeBio Pharma, Inc. Viking Global Investors Lp 18,602,920 9.70 0.00
2025-08-14 13D/A ORIC / ORIC Pharmaceuticals, Inc. Sr One Capital Management, Llc 4,615,384 4.75 0.00
2025-08-13 13D/A AUPH / Aurinia Pharmaceuticals Inc. ILJIN SNT Co., Ltd. 6,535,141 5.00 -13.33
2025-08-13 13D/A AVBP / ArriVent BioPharma, Inc. Orbimed Advisors Llc 3,027,328 7.50 0.00
2025-08-13 13D CVAC / CureVac N.V. Glaxosmithkline Plc 16,591,937 74.00 0.00
2025-08-13 13D PCSA / Processa Pharmaceuticals, Inc. HX Entertainment Ltd 5,467,181 10.90
2025-08-12 13D/A HRTX / Heron Therapeutics, Inc. Rubric Capital Management LP 29,100,728 17.50 8.94